Drug intelligence / Profile preview

undecoylium chloride iodine complex

Development stage: Unknown
Lead developer: Chesebrough Pond's
Modality: Small Molecules
Administration: Topical

Overview

**Undecoylium chloride iodine complex** is a formerly marketed topical antiseptic and antigermicidal small molecule. It is an iodine complex of the cationic surfactant undecoylium chloride, designed for local antimicrobial disinfection rather than systemic therapy. The substance was first approved in the United States in 1964 and was marketed as Virac; it has since been classified as a previously marketed drug in the United States. ([drugs.ncats.io](https://drugs.ncats.io/drug/O4CEK7FP0D))

Brand names: Virac
Other names: undecoylinium chloride-iodineundecoylium chloride complex with iodineundecoylium chloride iodineundecoylium chloride-iodine

Beyond the preview

Go deeper on undecoylium chloride iodine complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on undecoylium chloride iodine complex.

Explore the full profile